Cormac Purcell
About Cormac Purcell
Cormac Purcell is a Research Associate in mRNA Process Development at Tessera Therapeutics, where he enhances the company's RNA platform. He has a background in chemical engineering and has held various internships in the biotechnology field.
Work at Tessera Therapeutics
Cormac Purcell serves as a Research Associate in mRNA Process Development at Tessera Therapeutics since 2021. He operates in a collaborative start-up environment focused on enhancing the company's RNA platform. His role involves routine tasks such as DNA linearization, RNA synthesis, and enzymatic reactions. Purcell has contributed significantly to the scale-up efforts for manufacturing at Tessera, which is crucial for advancing the company's therapeutic developments.
Previous Experience in Biotechnology
Prior to his current position, Purcell gained valuable experience through several internships in the biotechnology sector. He worked as a Separations and Purification Intern at Bristol Myers Squibb in 2020, where he focused on manufacturing processes. In 2019, he interned at Harpoon Brewery as a QA/QC Laboratory Intern, and in 2018, he was an Analytical Development Intern at Acorda Therapeutics, Inc. These roles provided him with a solid foundation in laboratory practices and analytical techniques.
Education and Expertise
Cormac Purcell earned a Bachelor's degree in Chemical Engineering from Northeastern University, completing his studies from 2016 to 2021. His educational background equips him with the technical knowledge necessary for his role in RNA process development. Purcell's expertise includes optimizing In-Vitro Transcription of RNA to achieve low levels of double-stranded RNA (dsRNA) and high purity levels, which are critical for effective RNA applications.
Laboratory Skills and Techniques
In his role at Tessera Therapeutics, Purcell routinely performs essential laboratory techniques that are vital for RNA research and development. His work includes DNA linearization, RNA synthesis, and enzymatic reactions. These skills are fundamental in the optimization of RNA processes, contributing to the overall efficiency and effectiveness of the company's therapeutic initiatives.